(Q51557163)

7 April 2018

title

PALB2 analysis in BRCA2-like families. (English)

1 reference

7 April 2018

author name string

M A Adank

1

1 reference

7 April 2018

S E van Mil

2

1 reference

7 April 2018

J J P Gille

3

1 reference

7 April 2018

Q Waisfisz

4

1 reference

7 April 2018

H Meijers-Heijboer

5

1 reference

7 April 2018

language of work or name

English

0 references

publication date

26 June 2010

1 reference

7 April 2018

Breast Cancer Research and Treatment

published in

1 reference

7 April 2018

volume

127

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

357-362

1 reference

7 April 2018

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

A recurrent mutation in PALB2 in Finnish cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

PALB2 sequence variants in young South African breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Evidence against PALB2 involvement in Icelandic breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

PALB2 variants in hereditary and unselected Finnish prostate cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

The emerging landscape of breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Are PALB2 mutations associated with increased risk of male breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1001-1

10.1007/S10549-010-1001-1

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018